Antiarrhythmic drugs and management of ventricular arrhythmias

J. William Schleifer, Komandoor Srivathsan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

While many advances have occurred in the nonpharmacologic treatment of ventricular arrhythmias, antiarrhythmic medications remain indispensable in the acute treatment and prevention of recurrent ventricular arrhythmias. Additionally, it is important to understand the effects of medications on neurohormonal modulation and defibrillation thresholds. Some antiarrhythmics have specialized uses for specific arrhythmias, and some can be used in the electrophysiology lab for diagnostic testing and aid during ablations. In contrast, amiodarone is effective for various arrhythmias, but it has many extracardiac toxicities. This chapter discusses the pharmacology and clinical use of antiarrhythmics for diagnostic and therapeutic management of ventricular arrhythmias.

Original languageEnglish (US)
Title of host publicationPathophysiology and Pharmacotherapy of Cardiovascular Disease
PublisherSpringer International Publishing
Pages1101-1133
Number of pages33
ISBN (Electronic)9783319159614
ISBN (Print)9783319159607
DOIs
StatePublished - Jan 1 2015

Fingerprint

Anti-Arrhythmia Agents
Cardiac Arrhythmias
Amiodarone
Clinical Pharmacology
Electrophysiology

Keywords

  • Amiodarone
  • Antiarrhythmic medications
  • Cardioversion
  • ICD
  • Potassium channel blocker
  • QT interval
  • Sodium channel blocker
  • Ventricular arrhythmia
  • Ventricular fibrillation
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Schleifer, J. W., & Srivathsan, K. (2015). Antiarrhythmic drugs and management of ventricular arrhythmias. In Pathophysiology and Pharmacotherapy of Cardiovascular Disease (pp. 1101-1133). Springer International Publishing. https://doi.org/10.1007/978-3-319-15961-4_52

Antiarrhythmic drugs and management of ventricular arrhythmias. / Schleifer, J. William; Srivathsan, Komandoor.

Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, 2015. p. 1101-1133.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schleifer, JW & Srivathsan, K 2015, Antiarrhythmic drugs and management of ventricular arrhythmias. in Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, pp. 1101-1133. https://doi.org/10.1007/978-3-319-15961-4_52
Schleifer JW, Srivathsan K. Antiarrhythmic drugs and management of ventricular arrhythmias. In Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing. 2015. p. 1101-1133 https://doi.org/10.1007/978-3-319-15961-4_52
Schleifer, J. William ; Srivathsan, Komandoor. / Antiarrhythmic drugs and management of ventricular arrhythmias. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, 2015. pp. 1101-1133
@inbook{d3d7c8eba6d046ada0ba01c168741648,
title = "Antiarrhythmic drugs and management of ventricular arrhythmias",
abstract = "While many advances have occurred in the nonpharmacologic treatment of ventricular arrhythmias, antiarrhythmic medications remain indispensable in the acute treatment and prevention of recurrent ventricular arrhythmias. Additionally, it is important to understand the effects of medications on neurohormonal modulation and defibrillation thresholds. Some antiarrhythmics have specialized uses for specific arrhythmias, and some can be used in the electrophysiology lab for diagnostic testing and aid during ablations. In contrast, amiodarone is effective for various arrhythmias, but it has many extracardiac toxicities. This chapter discusses the pharmacology and clinical use of antiarrhythmics for diagnostic and therapeutic management of ventricular arrhythmias.",
keywords = "Amiodarone, Antiarrhythmic medications, Cardioversion, ICD, Potassium channel blocker, QT interval, Sodium channel blocker, Ventricular arrhythmia, Ventricular fibrillation, Ventricular tachycardia",
author = "Schleifer, {J. William} and Komandoor Srivathsan",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-15961-4_52",
language = "English (US)",
isbn = "9783319159607",
pages = "1101--1133",
booktitle = "Pathophysiology and Pharmacotherapy of Cardiovascular Disease",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Antiarrhythmic drugs and management of ventricular arrhythmias

AU - Schleifer, J. William

AU - Srivathsan, Komandoor

PY - 2015/1/1

Y1 - 2015/1/1

N2 - While many advances have occurred in the nonpharmacologic treatment of ventricular arrhythmias, antiarrhythmic medications remain indispensable in the acute treatment and prevention of recurrent ventricular arrhythmias. Additionally, it is important to understand the effects of medications on neurohormonal modulation and defibrillation thresholds. Some antiarrhythmics have specialized uses for specific arrhythmias, and some can be used in the electrophysiology lab for diagnostic testing and aid during ablations. In contrast, amiodarone is effective for various arrhythmias, but it has many extracardiac toxicities. This chapter discusses the pharmacology and clinical use of antiarrhythmics for diagnostic and therapeutic management of ventricular arrhythmias.

AB - While many advances have occurred in the nonpharmacologic treatment of ventricular arrhythmias, antiarrhythmic medications remain indispensable in the acute treatment and prevention of recurrent ventricular arrhythmias. Additionally, it is important to understand the effects of medications on neurohormonal modulation and defibrillation thresholds. Some antiarrhythmics have specialized uses for specific arrhythmias, and some can be used in the electrophysiology lab for diagnostic testing and aid during ablations. In contrast, amiodarone is effective for various arrhythmias, but it has many extracardiac toxicities. This chapter discusses the pharmacology and clinical use of antiarrhythmics for diagnostic and therapeutic management of ventricular arrhythmias.

KW - Amiodarone

KW - Antiarrhythmic medications

KW - Cardioversion

KW - ICD

KW - Potassium channel blocker

KW - QT interval

KW - Sodium channel blocker

KW - Ventricular arrhythmia

KW - Ventricular fibrillation

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84944145315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944145315&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-15961-4_52

DO - 10.1007/978-3-319-15961-4_52

M3 - Chapter

SN - 9783319159607

SP - 1101

EP - 1133

BT - Pathophysiology and Pharmacotherapy of Cardiovascular Disease

PB - Springer International Publishing

ER -